Literature DB >> 27025441

Prevalence of depression in patients with type 2 diabetes attended in primary care in Spain.

Cèlia Cols-Sagarra1, Flora López-Simarro2, Margarita Alonso-Fernández3, José Mancera-Romero4, M Paz Pérez-Unanua5, José Javier Mediavilla-Bravo6, Alfonso Barquilla-García7, Sònia Miravet-Jiménez2.   

Abstract

OBJECTIVES: To estimate the prevalence of known and undiagnosed depression in patients with type 2 diabetes attended in primary care setting in Spain, and to determine the factors associated with the presence of depression.
METHODS: This was a cross-sectional and multicenter study performed in a random sample of patients with type 2 diabetes attended in 21 primary care centers. Depressive symptoms were measured with the self-administered Patient Health Questionnaire (PHQ-9).
RESULTS: A total of 411 patients were analyzed (mean age 70.8 (SD 10.3) years; 53.8% women). 29.2% of patients met the diagnostic criteria of depression, of whom 17% had known depression and 12.2% undiagnosed depression (PHQ-9 score ≥10, without a previous diagnosis of depression). Depression was more common in women (43.4%; 95% confidence interval [CI] 34.5-52.3%), widow (33.3%; 95% CI 27.9-38.7%), and hypothyroidism (12.5%; 95% CI 8.7-16.3%). Cardiovascular risk factors, the degree of control, complications related to diabetes, antidiabetic therapy and the number of drugs were not associated with the presence of depression.
CONCLUSIONS: The prevalence of depression was high in patients with type 2 diabetes. However, in approximately 40% of patients depression was undiagnosed. The complications related to diabetes and antidiabetic therapy were not associated with the presence of depression.
Copyright © 2016 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Primary care; Type 2 diabetes

Mesh:

Year:  2016        PMID: 27025441     DOI: 10.1016/j.pcd.2016.02.003

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  6 in total

1.  The association between insulin therapy and depression in patients with type 2 diabetes mellitus: a meta-analysis.

Authors:  Xiaosu Bai; Zhiming Liu; Zhisen Li; Dewen Yan
Journal:  BMJ Open       Date:  2018-11-28       Impact factor: 2.692

2.  Prevalence and predictors of depression, anxiety, and stress symptoms among patients with type II diabetes attending primary healthcare centers in the western region of Saudi Arabia: a cross-sectional study.

Authors:  Alhussain Alzahrani; Abdulrahman Alghamdi; Turki Alqarni; Reem Alshareef; Abdullah Alzahrani
Journal:  Int J Ment Health Syst       Date:  2019-07-16

3.  Weight loss increases all-cause mortality in overweight or obese patients with diabetes: A meta-analysis.

Authors:  Yiqi Chen; Xue Yang; Juyang Wang; Yangshiyu Li; Dou Ying; Huijuan Yuan
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients.

Authors:  Inmaculada Guerrero Fernández de Alba; Antonio Gimeno-Miguel; Beatriz Poblador-Plou; Luis Andrés Gimeno-Feliu; Ignatios Ioakeim-Skoufa; Gemma Rojo-Martínez; Maria João Forjaz; Alexandra Prados-Torres
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

5.  Prevalence and Associated Factors of Diabetes Distress, Depression and Anxiety Among Primary Care Patients With Type 2 Diabetes During the COVID-19 Pandemic in Egypt: A Cross-Sectional Study.

Authors:  Hazem A Sayed Ahmed; Ahmed Mahmoud Fouad; Sally Fawzy Elotla; Anwar I Joudeh; Mona Mostafa; Asghar Shah; Jaffer Shah; Samar F Mohamed
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

6.  Prevalence of depression in patients with type 2 diabetes mellitus in Spain (the DIADEMA Study) : results from the MADIABETES cohort.

Authors:  Miguel Angel Salinero-Fort; P Gómez-Campelo; F Javier San Andrés-Rebollo; Juan Cárdenas-Valladolid; Juan C Abánades-Herranz; Enrique Carrillo de Santa Pau; Rosa M Chico-Moraleja; Domingo Beamud-Victoria; Jose M de Miguel-Yanes; Rodrigo Jimenez-Garcia; Ana López-de-Andres; Yolanda Ramallo-Fariña; Carmen De Burgos-Lunar
Journal:  BMJ Open       Date:  2018-09-24       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.